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CHAPTER I
INTRODUCTION AMD HISTORICAL
The first substantiated whooping cough epidemic occurred in 
Paris in 157Ô and was described by Guillaume Baillou. In earlier times 
whooping cough often assumed a more serious character than it does 
today. More than 120,000 died from it in England and Wales between 
1858 and 1865, and during a five year period from 1875 to 1880, 85,000 
people died from whooping cough in Prussia (Madsen, 1925)* While 
mortality from this disease has reduced steadily, its relative 
inç)ortance as a cause of death in children under five years of age 
has increased progressively, and now it is exceeded only by gastro­
enteritis, pneumonia and tuberculosis ( Burrows, 1959)* In Bulgaria, 
whooping cough, among the so-called “children's infections", is 
second only to measles in incidence and is first in mortality (Donchev 
and Stoyanova, I96I),
The etiological agent of whooping cough, Bordetella pertussis, 
was demonstrated positively, for the first time, in I9O6 by Bordet 
and Gengou at the Pasteur Institute, Brussels, Belgium, This organism 
had been isolated in 1900, but due to difficulties with the isolation 
and successful sub-cultivation of B , pert.ussis upon suitable media, 
they were unable to report their data until six years later. The first 
difficulty lay in the primary isolation of a pure culture of the 
organism from the sputum and exudate of a patient diagnosed as having
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whooping cough. It was observed (Bordet and Gengou, 1906) that, in 
cases favorable for the recovery of the organism, an almost pure 
culture of the whooping cough bacillus could be obtained from a 
bronchial exudate, rich in leucocytes, which was eliminated by a 
cough. However, it was also observed that this held true only at the 
start of the paroxysmal stage of the disease, and, if the leucocytic 
exudate was examined on successive days, although the coughs remained 
numerous and characteristic, the number of specific organisms re­
covered became visibly less and phagocytosis was found more frequently. 
The problem of recovering B, pertussis from pharyngeal exudates or 
swabs was further complicated by the presence of innumerable bacterial 
rivals which would quickly overgrow the etiological agent on almost 
all artificial media (Bordet and Gengou, I9O6; Lacey, 1954)#
In 1900 Bordet and Gengou recovered an organism from the 
bronchial exudate of a six month old infant, diagnosed as having whoop­
ing cough. Since the child had no previous history of any respiratory 
infections, they believed this organism to be the true causative 
agent of the disease, and were thus disappointed when they were unable 
to culture it upon any of the customary media. However, by the time 
they made a second recovery of these bacilli under similar circum?- 
stances, a new medium, the Bordet-Gengou potato extract-blood—agar 
medium, had been developed which was suitable for le microbe de la 
coqueluche (Bordet and Gengou, I906),
As soon as the problem of cultivation of B, pertussis was solved
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
-3-
another problem took its place. Although freshly isolated strains of 
B. pertussis are immunologically homogeneous, i.e., the virulent form 
occurs only as a single antigenic type (Leslie and Gardner, 1931; 
Lawson, 1939; Ungar and Stevens, 1951; Breed et al., 1957), all 
strains undergo a slow degradation even on blood media. Leslie and 
Gardner (1931) found four successive stages of degradation in 
pertussis organisms which they termed Phases I, II, III and IT. Later, 
Lawson (1939) demonstrated all of these phases except Phase II, It 
was suggested in 1935 by Toomey et al. and later by Standfast (1951) 
and Burrows (1959) that the stages should not be arbitrarily limited 
to phases, but divided instead into broader groups such as ’’virulent'’ 
and "avirulent", corresponding to the smooth-rough dissociation ob­
served in other bacteria. This degradation occurred on most artificial 
media, but most rapidly on media which do not include blood or a 
blood substitute.
This need for fresh, defibrinated blood in the culture medium, 
together with a morphological resambience of B. pertussis to Pfeiffer’s 
bacillus (Haemophilus influenzae)originally led to the incorporation 
of the Bordet-Gengou bacillus into the genus Haemophilus, Later 
discoveries that neither the X nor V factor was required for growth 
(Breed et al,, 1957; Rowatt, 1957(h) ), that metabolic differences 
existed between B, pertussis and the other Haemophilus species (Meyer 
and Cameron, 1957; Cowan and Steele, 1961) and that there were strong 
morphological, cultural and immunological similarities between H.
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pertussis. Brucella bronchiseptica and the parapertussis bacillus 
(Ferry and Klix, 1918; Ferry and Noble, 1918; Bradford and Slavin,
1937; Eldering and Kendrick, 1938; Eldering and Kendrick, 1952; 
Moreno-Lopez, 1952; Proom, 1955) led eventually to the formation of 
a new genus, Bordetella. which included all three species: B. pertussis, 
B. parapertussis. and B, bronchiseptica.
The necessity for incorporation of fresh blood in the Bordet- 
Gengou (B-G) medium was found to be due to an adsorptive rather 
than a nutritive quality, serum albumin being the most important 
constituent (Pollock, 1949; Dawson et al., 1950). Blood can be 
replaced in agar and semi-synthetic fluid media by starch (Homibrook, 
1940; Cohen and Wheeler, 1946; Pollock, 1949; Ungar et al., 1950), 
charcoal (Ensminger et al., 1934; Ungar et al., 1950; Mishulow, Sharpe 
and Cohen, 1953; Abe, 1953; Turner, 1961; Holt, 1962), and glass 
beads or anion exchange resins (Kuwajima, Matsui and Kishigami, 1958)# 
Unsaturated fatty acids have been shown to be hi^ly inhibitory 
toward B, pertussis (4 /ig/ml by Pollock, 1945; 20 pg/ml by Rowatt, 
1957(a) ) and it was felt that the protective action of these sub­
stances lay in their ability to adsorb from the medium an oleic 
acid-like substance produced by the cells during growth (Pollock,
1949; Kuwajima, Matsui and Kishigami, 1958).
Growth of B. pertussis in liquid media is also inhibited by 
autoclaved cysteine, sulfides and colloidal sulfur (Rowatt, 1957(a); 
Rowatt, 1957(b); Schuhardt et al., 1952). Inhibition due to auto—
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claved cysteine may be overcome by Seitz filtration, addition of 
serum albumin or the substitution of glutathione for cysteine in 
the medium. The action of another growth inhibitor of B, pertussis, 
a peroxide-like substance, may be counteracted or overcome by the 
addition of certain substances to the medium, such as red blood 
cells, haematin, cobalt, charcoal, cupric, ferrous and ferric ions, 
serum fractions, cysteine and several surface-active agents (Gilder 
and Granick, 1948; Rowatt, 1957(a); Barry et al., 1956).
The difficulties frequently encountered in growing B, pertussis 
are probably due to the presence of these inhibitors in the medium, 
since the nutritional requirements of the organism are not elaborate. 
Apparently the only essential nutrients for this organism are 
nicotinic acid and amino acids.(Jebb and Tomlinson, 1955; Turner,1961) 
Nicotinic acid was required by all species of Bordetella (Fukimi et al#, 
1953; Jebb and Tomlinson, 1955) and appeared to serve the same 
function as yeast dialysate or cozymase. Apparently, given the 
nicotinic acid residue, B. pertussis was capable of synthesizing 
the cozymase molecule (Hornibrook, 1940; James, 1949)* Purines, haemin 
and biotin all enhance growth but were not essential (Jebb and 
Tomlinson, 1955)*
The choice of a sulfur-source for B, pertussis appears to be 
somewhat limited. It is generally agreed that cystine and cysteine 
are suitable for this purpose (Fukimi et al,, 1953; Abe, 1953; Proom, 
1955; Imamura, 1952; Jebb and Tomlinson, 1957) and in some cases it
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was felt that they were essential for the growth of the organism 
(Proom, 1955; Imamura, 1952). Abe (1953) and. Jebb and Tomlinson 
(1957) also found glutathione to be utilisable as a sulfur-source. 
Reports on other substances are varying and contradictory. ^0, was 
found satisfactory by Fukimi et al. (1953) and Abe (1953). Abe also 
found that thioglycollate and Na^S supported good growth. Imamura 
(1952) confirmed this for sodium thioglycollate, but obtained only 
slight growth with sulfide. Jebb and Tomlinson (1957) reported no 
growth with sodium sulfate, thiosulfate, taurine, sodium hydrosulfate, 
sulfite, sodium sulfide, homocystine, methionine, mercaptoacetic 
acid or cysteic acid, Abe reported good growth with methionine, and 
Imamura (1952) sli^t growth with both methionine and taurine.
Negative results were obtained for methionine by Fukimi et al. (1953) 
and for taurine by Abe (1953)* It would appear to be fairly conclu­
sive that B. pertussis is incapable of utilizing sulfate, most 
inorganic and many organic sulfur compounds as sources of sulfur.
Amino acids serve as a source for carbon, nitrogen and energy 
in B. pertussis. The nitrogenous elements in the potato extract of 
B-G agar appear to be the main source of nutrition for B. pertussis; 
the extract probably furnishes optimal concentrations of amino acids 
and peptides for growth (Dawson et al., 1950; Dawson et al., 1951)* 
The major metabolic activity of B. pertussis is the oxidation of 
amino acids (Rowatt, 1957(b) ). Glutamic acid is the amino acid most 
readily oxidized by resting cell suspensions (Jebb and Tomlinson,
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1951; Abe, 1953; Meyer and Cameron, 1957) and best able to support 
growth in semi-defined media (James, 1949; Dawson et al., 1950; 
Imamura, 1952; Fukimi et al., 1953; Rowatt, 1955, Rowatt, 1957(a) ), 
Aspartic acid, proline, alanine and serine follow glutamic acid in 
metabolic importance. Proline, or, to a lesser degree, aspartic acid 
could replace glutamic acid for growth in the Medium D of Fukimi 
et al, (1953) but not arginine, alanine, glycine, citrulline or 
histidine. Imamura (1952) reported satisfactory growth (10-12 
billion organisms/ml) in synthetic medium containing only two amino 
acids, cystine and glutamic acid. The glutamic acid could be replaced 
in this medium by proline, but not histidine, arginine, glycine or 
phenylalanine. Glutamic acid, aspartic acid, serine, glycine and 
proline are completely removed from the medium by both virulent and 
avirulent strains in 12-15 days, whereas threonine and alanine are 
only partially used,(James, 1949).
Jebb and Tomlinson (1955) found that omission of glycine pre­
vented growth whereas the omission of glutamic acid or cystine re­
stricted growth markedly. They felt that although glutamic acid is 
not essential for growth, it is the amino acid present in the highest 
concentrations, is most rapidly oxidized by resting suspensions and 
is probably a principal energy source. When glutamic acid was replaced 
with aspartic acid, proline and lactate only 30-60$ of the growth
attained with glutamic acid was observed.
Inhibition due to valine could be overcome by the addition of
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leucine or isoleucine, but preferably by both together. Conversely, 
methionine, proline and serine were found to be inhibitory singly or 
in pairs, but especially when all three were together; an inhibition 
which was overcome by the addition of glycine (Jebb and Tomlinson, 
1955).
Since B* pertussis mainly utilizes amino acids for growth, 
particularly glutamic acid, it is most probable that new substances 
enter the energy-rich tricarboxylic acid (TGA) cycle in the form of 
d-ketoglutaric acid. The first step in the oxidation of glutamate 
by B* pertussis is deamination to -ketoglutaric acid since it has 
been demonstrated that cells oxidizing glutamic acid in the presence 
of arsenate produced -ketoglutarate.(Jebb and Tomlinson, 1951j 
Rowatt, 1957(b) ). In simple amino acid mixtures, glutamic acid was 
replaced only by an alternate source of energy, namely Cj —keto— 
glutaric acid (Proom, 1955). Fukimi et al, (1953) suggested that 
the amino acids capable of replacing glutamic acid in media are 
those which can be converted to it in the metabolic pathway:
glutamic acid proline <— ornithine
"f 4̂
serine hydroxyproline arginine
glycine cysteine 
Several workers have demonstrated the probablity of an operative 
TCA cycle in B, pertussis. Fukimi et al, (1953) reported that pyruvic 
acid, acetic acid, citric acid, c(-ketoglutaric acid, fumaric acid 
and malic acid were readily oxidized by each member of the pertussis-
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paxapertussis-bronchiseptica group of organisms, Jebb and Tomlinson 
(1951) confirmed oxidation with lactate, succinate, c)-ketoglutarate 
and pyruvate, but found no oxidation with oxaloacetate, fumarate, 
malate, propionate, acetate and formate. Succinic acid, c| —keto— 
glutaric acid, fumaric acid and citric acid were shown by Abe (1953) 
to be the TCA cycle intermediates most readily oxidized by washed 
cell suspensions of B. pertussis.
Fukimi et al, (1953) demonstrated the presence of aconitase 
and the production of -ketoglutaric acid from citric acid. From 
his work, he postulated that a full tricarboxylic acid cycle is 
operative in the genus Bordetella. but he denied the reversal of the 
glutamate to -ketoglutarate reaction on the grounds that glutamate 
is required for growth, Seim (I963) also demonstrated the enzymes of 
the TGA cycle in cell-free extracts of B, pertussis. Most notable 
was the demonstration of a fumarase and a diphosphopyridine nucleo­
tide—linked malic dehydrogenase activity, since, both Jebb and 
Tomlinson (1951) and Abe (1953) showed little or no oxidation of 
these substrates (fumarate and malate) with washed cell suspensions 
of B. pertussis.
Although B. pertussis possesses a TCA cycle and is capable of 
metabolizing pyruvic acid, it does not utilize any of the common 
sugars aerobically or anaerobically (Ungar et al., 1950; Jebb and 
Tomlinson, 1951;Fukimi et al., 1953; Jebb and Tomlinson, 1955; Abe, 
1953; Rowatt, 1957(b); Breed et al.,1957). Jebb and Tomlinson (1951)
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found that glucose, maltose, sucrose, lactose and starch were not 
oxidized or fermented by washed suspensions of B. pertussis nor did 
any fermentation occur during growth with 1% (w/v) solutions of 
glucose, fructose, maltose, galactose, lactose, sucrose, glycerol, 
adonitol, arabinose, rhamnose, mannitol, dulcitol, sorbitol or 
raffinose. Abe (1953) reported that B. pertussis showed no o q̂rgen 
uptake with solutions of sucrose, lactose, trehalose, glucose, 
galactose, rhamnose, inositol, xŷ lose, arabinose, mannitol, sorbitol, 
dulcitol, inulin or salicin. He did find, however, that a small 
amount of oxygen consumption occurred with glucosamine. He (Abe,
1953) maintained that a carbohydrate to triose phosphate to pyruvic 
pathway can not exist in B, pertussis because sugars are not 
oxidized and alanine did not stimulate growth, and, because of the 
high oxidation activity of B, pertussis on succinate and c/-keto­
glutarate, suggested a metabolic cycle according to the scheme:
CCL
carbohydrate alanine acetic acid .ç* formic acid^
^  ^  ^  H^O
'1— pyruvic acid ■— active acetate~> citric acid
aspartic acid j 11 cÿ -ketoglutaric acid
oxaloacetic acid succinate glutamic acid
t  4 t
malic acid *- fumaric acid proline, hydroxypro­
line
In spite of the fact that B, pertussis is remarkably inactive 
toward carbohydrates and is apparently unable to utilize them either 
for growth or energy, the organism does contain polysaccharides and
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nucleic acids (Eldering, 1942; Overend et al,, 1951; Smolens and 
Vogt, 1953) and must be capable of metabolizing carbohydrates 
sufficiently for incorporation into the cell substance, although 
the major metabolic activity of the cell may be the oxidation of 
amino acids. The question therefore arises as to what pathway 
is utilized by B, pertussis for the synthesis of these cellular 
polysaccharides. Although a pathway from external carbohydrates to 
pyruvic acid might not exist, it is probable that a pyruvic acid to 
cellular carbohydrate pathway does exist. The Embden-Meyerhof path­
way of glycolysis, one of the major mechanisms for the metabolism 
of carbohydrates in living cells, is capable of operating either 
toward or from pyruvic acid. In an attempt to further clarify the 
problem of carbohydrate metabolism in B, pertussis, cell-free extracts 
of this organism were examined to determine whether or not they 
possessed all or any of the enzymes of glycolysis.
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CHAPTER II
STATEMENT OF PROBLEM
Amino acids are deaminated by Bordetella pertussis and a 
tricarboxylic acid cycle is presumed to be operative in it. Apart 
from this, very little work has been done to elucidate the various 
metabolic pathways of this organism.
Although B. pertussis does not utilize any of the common sugars 
for energy or growth, it does contain polysaccharides and nucleic 
acids. It was felt that an examination of cell-free extracts for 
the enzymes of the Embden-Meyerhof pathway of glycolysis might shed 
some light upon the possible mechanism of carbohydrate synthesis 
in B. pertussis.
— 12—
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CHAPTER III
METHODS AND MATERIAIS
I. GENERAL METHODS AND MATERIALS
(1) Organisms employed;
Three strains of Bordetella pertussis were used throughout 
these experiments and 1 strain of Escherichia coli was occasionally 
used as a control organism.
Laboratory strains #1, #2 and #4 of B. pertussis were kindly- 
donated by Dr. John J, Munoz, formerly Director of the Stella 
Duncan Memorial Research Institute, Montana State University, and 
presently at the Rocky Mountain Laboratory, Hamilton, Montana* Strains 
1, 2 and 4 were originally designated as strains 292?* 5375L45 
and 5373L-2 respectively.
Strain ATGC 9637 of E. coli was used in those experiments 
requiring a control organism,
(2) Culture media;
For the maintenance of stock cultures, preliminary growth and 
primary isolation, the blood-potato extract-agar medium described 
by Bordet and Gengou (1906) still remains the solid medium most 
suited to the needs of B, pertussis. The Bordet-Gengou (B-G) medium 
was prepared as follows:
—13—
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30 g B-G agar base Difco
10 g proteose peptone Difco
1 1  \% solution of glycerol Allied Chemicals
Heat to boiling to dissolve completely; dispense in 170 ml lots
into 500 ml Erlenmeyer flasks; autoclave 15 minutes at 15 pounds
0pressure; cool to 45-50 0 and add aseptically 30 ml of sterile,
defribinated, fresh rabbit blood. Dispense aseptically into sterile,
screw-capped, 16 x 125 nma test tubes.
Medium GM-2H, a modification of the semi-synthetic fluid
medium of Cohen and Wheeler (1946), was used to obtain large cell
crops of B, pertussis. It was prepared in the following manner:
Casamino Acids 
Yeast extract 
Niacin
Glutathione(reduced)
MgC1^.6HzO 
KHpPO^ (anhyd)
Soluble starch 
GaClg* 2H%0,1,00$ sol,
FeS0^'7H%0,0,50^ sol,
CuSO^-5H*0,0.05^ sol.
Distilled water
Adjust pH to 6,8 with 1
distilled water until it is dissolved and clear, then add it to the 
rest of the medium. Dispense the medium in 200 ml aliquots into 1 
liter Blake bottles, then autoclave for 20 minutes at 15 lbs,
(3) Chemicals;
The chemicals employed in these experiments were:
Bacto tech., Difco 14.0 g
Difco 1.5 g
Nutritional Biochemicals Co. 0,02 g
Nutritional Biochemicals Co, 0.01 gMerck, Reagent 0.1 gBaker, Reagent 0,5 gFisher, Reagent 1.0 gFis her. Reagent 1.0 ml
Allied Chemicals, Reagent 2,0 ml
Mallinckrodt, Reagent 1.0 ml
1.0 1
NaOH, Heat the starch in a small amount of
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(a) Substrates:
anhydrous
Barium
Barium
Sodium
Glucose
Fructose-6-phosphate 
Glue o s e-6-pho sphat e 
Fructose-l,6-diphosphate 
Glyceraldehyde—3-phosphate Barium 
3—Phosphoglyceric acid Barium
Pho spho enolpyruvic acid 
dl-Malic acid
Barium
anhydrous
Allied Chemicals 
Nutritional Biochemicals 
Sigma 
Sigma
Nutritional Biochemicals 
Nutritional Biochemicals 
Sigma
Nutritional Biochemicals
(b) Purified enzymes:
Glucose-6-phosphate dehydrogenase (Zwischenferment) Sigma
cj—Glycerophosphate dehydrogenase/triosephosphate isomerase Sigma 
d-Glycerophosphate dehydrogenase Sigma
Triose phosphate isomerase Sigma
Glyceraldehyde-3-phosphate dehydrogenase Sigma
(c) Goenzymes, etc.:
Triphosphopyridine nucleotide (TPN) Nutritional Biochemicals
Diphosphopyridine nucleotide (DPN) Nutritional Bio chemicals
Coenzyme 1 (reduced) (DPNH) Nutritional Biochemicals
Adenosine triphosphate (ATP) Nutritional Biochemicals
Adenosine diphosphate (ADP) Sigma
The insoluble barium ion of the carbohydrate substrates was 
exchanged for sodium ion by the general method of DeMoss (1955)* A 
certain weight of the substrate (depending upon the total number of 
pmoles of substrate desired in the final volume of solution) was 
dissolved in approximately 5 ml of 0.1 N HCl. The barium ion was re­
moved by the addition of saturated N^SOy. solution. The solution was 
centrifuged to settle the precipitate, and a few more drops of 
saturated sodium sulfate solution were added to the supernatant fluid 
to insure the con^lete removal of barium in the form of insoluble 
barium sulfate. The supernatant fluid was removed by means of a
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capillary pipette and its pH was adjusted to a range of 7*0-8,0 with 
0,2 N NaOH. The substrate solution was then diluted to the desired 
final volume (usually 10 or 20 ml) with distilled water.
(4) Buffer solutions;
A 0.15 M phosphate buffer, pH 7.0, was used for washing the 
cells and suspending the extracts (Jyssum, 1959), since any of the 
organic buffers used in the experiments would interfere with the 
nitrogen determinations of the extracts. This buffer was prepared 
by mixing 611 ml of a 0,15 M solution of disodium phosphate (Fisher 
certified reagent, Na^HPO^» 7H^0) with 389 ml of a 0,15 M solution 
of monopotassium phosphate (Baker analyzed reagent, KI^PC^) to make 
1 liter of buffer, pH 7*0.
Barbital and Tris buffers, 0.05 M, were prepared according to 
the method of Gomori (1955)*
(a) Barbital buffer
At 0,2 M solution of sodium barbital (veronal) (41*2 g in 1 l) 
Bt 0,2 M HCl
50 ml of solution A plus x ml of B, diluted to 200 ml,
2 £2-
9*0 8,4
12,7 8,2
17.5 8.0
22.5 7.8
(b) Tris (hydroxymethyl) aminomethane (Tris) buffer
A: 0,2 M solution of Tris (24*2 g in 1 1)
B: 0,2 M HCl
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50 ml of solution A plus x ml of B, dilutied to 200 ml.
X £H
26.8 8.0
32.5 7.8
38.4 7.6
41.4 7*4
44.2 7.2
Sterile physiological saline solution (8,5 g NaCl in 1000 ml) 
was used to transfer growth from B-G slants to liquid CM-211 in 
Blake bottles.
(5) Maintenance of cultures;
Reserves of the stock cultures were kept in the freezer in the 
lyophilized state. When needed, new vials were opened and the contents
transferred aseptically by means of sterile capillary pipettes and
sterile saline, to slants or petri dishes containing B-G agar. They 
were allowed to incubate at 37 0 for 3-4 days before a second transfer 
onto B—G slants was made.
Stock cultures were grown on B-G slants, incubated for 2 days 
at 37**C, then kept in the refrigerator for a week for subculturing.
Cells for experiments were grown on B-G slants for 2 days at 
37*C, then they were transferred in sterile saline to 2 Blake bottles, 
each of which contained 200 ml of CM-211, The Blake bottles were 
then incubated for 2 days in a nearly horizontal position on a shaker
Okept in a warm roon at a temperature of about 35 C. The growth in 
these was checked for purity by a Gram stain; then a 30 ml inoculation
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was made from 1 of these bottles into each of 4 fresh bottles of 
CM—211* The bottles containing the secondary transfer were incubated 
for 24 hours on the shaker in the warm room^ at the end of Wiich 
time the cells were harvested*
E, coli stock cultures were kept in the refrigerator on nutri­
ent agar slants until needed. For experiments they were incubated for 
24 hours at 37**C, for 2 successive subcultures on nutrient agar; then 
they were inoculated into 500 ml Erlenmeyer flasks containing 100 ml 
of nutrient broth. The cells were incubated on the shaker for 24 
hours and then harvested in the same manner as the B, pertussis cells*
(6) Cell preparationss
After Gram staining to check for purity of cultures, the con­
tents of the Blake bottles were poured into 250 ml, screw-capped, 
Nalgene centrifuge bottles and centrifuged in a refrigerated Inter­
national centrifuge (5^0) at 3500 rpm for 30 minutes.
The harvested cells were washed with 0,15 M phosphate buffer,
pH 7*0, transferred to 50 ml celluloid centrifuge tubes and
centrifuged at 5000 rpm for 10 minutes in a Super Speed Servall
centrifuge which was kept in a cold room* The cells were then washed 
and centrifuged twice in the same manner.
After the final washing, the crude enzyme preparation was 
extracted from the cell paste in accordance with the method of 
Gunsalus (1955). In a chilled mortar, the cell paste, 1 or more parts
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of alumina and 5 ml of phosphate buffer were subjected to vigorous 
hand grinding for 2-5 minutes. The mixture was diluted with more 
buffer, transferred to stainless steel, 50 ml centrifuge tubes and 
centrifuged at 13,000 rpm for 20 minutes in a Super Speed Servall 
centrifuge. This was all done in the cold room. The supernatant 
fluid containing the crude enzyme preparation was transferred to a 
test tube and used on the same day it was prepared. Unused extract 
was stored in screw-capped tubes in the refrigerator for later 
nitrogen determinations.
(7) Determination of nitrogens
The nitrogen content of the enzyme preparations was determined 
by the colorimetric method of Johnson (1941)® A sample containing 
10 to 40 micrograms of nitrogen was pipetted into an IS x 150 mm 
Pyrex test tube. One ml of 2 N I^SO^ containing 0,2 g per liter of 
CuSeO^ was added, and the tube was covered with a stainless steel 
cap, A glass bead was added to the tube to prevent excessive 
splattering while the contents were digested overnight in an elec­
trically controlled digestion rack kept at 105"c. To the tube, after 
digestion, were added in orders 2 ml of water, 2 ml of color reagent 
and 3 ml of 2 N NaOH, The color reagent contained per liter: 4 g of 
KI, 4 g of Hgl;t, and 1,75 g of gum ghatti. After standing 15 minutes, 
the tube was placed in a Coleman Junior spectrophotometer and a 
reading taken at a wavelength of 49^ mjj.. Blanks and nitrogen
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standards were used each time a determination was done^ and the 
nitrogen determinations of the enzyme preparations were always done 
at least in duplicate*
(8) Spectrophotometric methods:
For all reactions involving a pyridine nucleotide-linked 
enzyme a Beckman spectrophotometer. Model DB, was used to measure 
the enzyme activity by the rate at which the reduced form of the 
coenzyme used appeared or disappeared from the reaction mixture*
DPNH and TPNH absorb light strongly at a wavelength of 340 mji. This 
wavelength lies in the upper limits of the visible light range and 
in the lower limits of the ultraviolet range, hence either a tungsten 
or a hydrogen lamp may be used as a light source in these experiments* 
Pyrex cuvettes with a 3 ml volume and a 1 cm light path were 
used to contain the reaction mixtures and the reaction rates were 
measured at a wavelength of 340 mp with a tungsten lamp light source*
II* EXPERIMENTAL METHODS AND MATERIALS
(l) Glucose—6-phosphate dehydrogenases
This enzyme catalyzes the conversion of glucose-6-phosphate 
(G—6-P) to 6-phosphogluconolactone and is coupled with the reduction 
of either TPK or DPN, The method used was that of Jyssum, Borchgrevink 
and Jyssum (1961),
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The reaction mixture contained 100 pmoles barbital buffer^ 
pH 8.0; 0.5 ml extract; 10 paoles G-6-P; and, the reaction proper 
was started at zero time with the addition of 0.25 paole of TPN.
Endogenous (without substrate) and reagent (without extract) 
blanks were run for each strain. All were read against a blank 
containing extract, buffer and water to a final volume of 3 ml.
In certain experiments 0.02 ml of purified G—6—P dehydrogenase 
was added to the reaction mixture, and in one experiment 0.25 pnole 
of DPN was substituted for the same amount of TPN.
(2) Hexokinase:
Mg ions and ATP are necessary for the hexokinase reaction to 
proceed (Berger et al,, 1946). Hexokinase phosphorylates glucose to 
P. To demonstrate this enzyme it was necessary to couple this 
reaction with the TPN-linked G—6—P reaction and proceed as above 
(Jyssum, Borchgrevink and Jyssum, 1961).
The reaction mixture contained 100 jumoles barbital buffer, 
pH 8.0; 0.5 ml cell-free extract; 20 pmoles glucose; 2 jumoles ATP;
5 pnoles MgClg'él^Û; 0.02 ml G—6—P dehydrogenase from yeast; and, 
after these reagents were incubated in the cuvette for 5 minutes 
at room tençierature, the reaction proper was started with the addition 
of 0.25 jLimole of TPN, Readings were made every 15 seconds after zero 
time for from 1 to 5 minutes.
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(3) Phosphohexoisomerase;
Two methods were used in sin attempt to demonstrate the presence 
of a phosphohexoisomerase in B« pertussis» The first method (a), as 
in the case of hexokinase, was coupled with the spectrophotometric 
demonstration of the formation of G—6-P (Jyssum^ Borchgrevink and 
Jyssum, 1961), The second method (b) was based uoon both the method 
of Hacker (1947) for the demonstration of hexokinase and phospho— 
fructokinase and the method of Jyssum, Borchgrevink and Jyssum (I96I) 
for the demonstration of phosphofructokinase and aldolase activity.
(a) This enzyme catalyzes the isomerization of G-6-P to fructose— 
6-phosphate (F-6—P) and vice versa, resulting in an equilibrium 
mixture containing 10% of the glucose isomer (Axelrod, 1960(a)).
The reaction mixture contained 100 pmoles barbital buffer, 
pH 8,0; 20 pmoles F-6-P; 0.5 ml cell-free extract; and 0,02 ml of 
added G-6-P dehydrogenase. After incubating the reagents for 5 
minutes at room temperature, the reaction was started with the 
addition of 0,25 pmole TPN,
In one experiment the cells were washed and the extract 
suspended in barbital buffer, pH 7.0, rather than the customary 
phosphate buffer,
(b) This method is dependent upon the previous demonstration by 
similar means of both phosphofructokinase and aldolase,
100 pnoles barbital buffer, pH 8,0; 20 pmoles G-6-P; 0.2 ml
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cell-free extract; 5 pmoles MgCl^» ̂ H^O; 2 pnoles ATP; 10 pnoles 
niacin; 3,2 pnoles KCN; and 0,01 ml of a mixture of glycerophosphate 
dehydrogenase and triosephosphate dehydrogenase (GDH/TIM) were 
incubated for 30 minutes in test tubes in a water bath set at 37'"C,
At the end of this time, the contents of the tube were transferred to 
a cuvette and 0,5 pnole of DPNH was added to start the reaction,
(4) Aldolase:
The method chosen for the demonstration of aldolase in B, 
pertussis was that of Jyssum, Borchgrevink and Jyssum (I96I) which 
couples the aldolase reaction, a cleavage of fructose-1,6-diphosphate 
(FDP) to dihydroxyacetone phosphate (DHAP) and glyceraldehyde-3- 
phosphate (GA-3—P), with the 0(—glycerophosphate dehydrogenase-CPNH 
reaction. Cyanide and hydrazine favor the formation of triose 
phosphate (Axelrod, 1960(a); Taylor, 1951) and cyanide probably 
inhibits the reoxidation of reduced coenzyme (Jyssum and Borchgrevink,
i960)»
In a water bath held at 37^0 100 pnoles barbital buffer, pH 8.0, 
0.1 ml cell-free extract, 10 pnoles niacin and 3.2 pnoles KCN were 
incubated for 7 minutes. Then 20 pmoles FDP and 0,01 ml GDH /TIM were 
added and the reaction mixture incubated for a further 20 minutes. At 
the end of this time, the contents were transferred to a Pyrex cuvette 
and the reaction started by the addition of 0,5 pnole DPNH,
There is an alternative procedure for the demonstration of
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aldolase activity (Christian, 1955). However, this method, utilizing 
the DPN—linked GA—3—P dehydrogenase system, is impracticable with 
crude extracts, since the presence of triosephosphate isomerase and 
C3-glycerophosphate dehydrogenase in the extract will interfere 
greatly, the equilibrium between the triose phosphates being far 
in favor of DHAP and glycerophosphate formation (Hacker, 1947;
Ling, Byrne and Lardy, 1955).
(5) Phosphofructokinase:
This enzyme also requires MgCl^ and ATP for activity, since it 
catalyzes the phosphorylation of F—6—P to FDP, The method is the 
same as method (b) for phosphohexoisomerase except that 20 ^oles 
of F—6-P are used as substrate instead of an equal amount of G—6—P,
100 jmioles barbital buffer, pH 8.0; 20 pmoles F-6-P; 0,2 ml 
cell-free extract; 2 pmoles ATP; 5 pmoles MgCl^'ôH^O; 10 pmoles 
niacin; 3.2 pmoles KCN; and 0.01 ml GDH/TIM are incubated in test 
tubes for 30 minutes in a water bath held at 37 C. The contents are 
then transferred to a cuvette and the reaction started with the 
addition of 0,5 pmole DPNH at zero time.
(6) Triose phosphate isomerase:
An adaptation of the method of Jyssum, Borchgrevink and Jyssum 
(1961) for aldolase was used to demonstrate the presence of this 
isomerase which establishes an equilibrium between DHAP and GA—3—P#
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The mixture contained 100 yunoles barbital buffer, pH 8.0; 0.5 ml 
cell-free extract; 10 jjmoles GA-3-P and 0.001 or 0.0001 ml of a 
purified -glycerophosphate dehydrogenase, and the reaction was 
started with the addition of 0,5 pmole DPNH,
(7) of —glycerophosphate dehydrogenase;
Basically the same method was used to demonstrate this enzyme, 
which causes the reduction of DHAP to C\-glycerophosphate, as was 
used for the triose phosphate isomerase. However, the purified 
CX-glycerophosphate dehydrogenase was omitted and the system was 
used either without any added enzyme, or with 0,01 ml of purified 
triose phosphate isomerase,
(8) Phosphoglyceroklnaset
In the presence of ATP and Mg ions this enzyme will catalyze 
the formation of 1,3-diphosphoglyceric acid from 3~phosphoglyceric 
acid (PGA). This system is coupled with the enzyme GA—3—P dehydrogenase 
which, when in the presence of DPNH, will form GA—3—P from 1,3—diPGA*
The reaction mixture contained 75 pmoles barbital buffer, pH 
8.0; 5 pnoles MgCl^* 6H^0; 5 pnoles glycine; Ipmole ATP; 3,2 pnoles 
KCN; 0.5 ml cell-free extract; 20 pnoles 3-PGA and 0,02 ml purified 
GA-3—P dehydrogenase. These reagents were incubated for 7 minutes at 
room tenq)erature and then the reaction was started by the addition 
of 0.5 pnole DPNH.
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Glycine is used to bind traces of copper which strongly 
inhibit the activity of GA-3-P dehydrogenase (Christian, 1955).
Both 0.02 and 0,2 ml aliquots of purified GA—3—P dehydrogenase 
were used in these experiments with no significant differences 
appearing in the results,
(9) Giveeraldehyde-3-phosphate dehydrogenase;
The method used for the demonstration of this enzyme was the 
same as that used to demonstrate phosphoglycerokinase, except the 
addition of the purified enzyme was omitted,
(10) Pyruvate kinase:
This demonstration was based upon the formation of pyruvic 
acid from phosphoenolpyruvie acid by the enzyme pyruvic kinase. The 
incubation mixture was a modification of that used by Jyssum, 
Borchgrevink and Jyssum (I96I), It contained 10 pmoles of phosphoenol- 
pyruvic acid (PEPA); 3 pmoles MgClz.'6H;lO; 10 pmoles ADP; 1 ml extract 
in Tris buffer, pH 7,4 and 10 pmoles KCl, Potassium ion appears to 
be required for this reaction (Axelrod, I96O (a) ). Reagent and 
endogenous blanks were made up for each strain and all were brought 
up to a final volume of 3 ml with distilled water. The tubes were 
incubated for a suitable length of time (the exact time varied; 
usually being 1 hour); then the samples, together with 2 or 3 blanks 
containing 3 ml of 5# acetic acid, were analyzed for pyruvic acid
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content by the method of Friedmann (1957).
All tubes were incubated 10 minutes in a water bath held at 
25 -2“C. At accurately timed intervals (30") 1.0 ml of a 0.1# 
solution of 2,4-dinitrophenylhydrazine in 2 H HCl was added to 
each tube. Incubation was continued at 25^0 for 5 minutes^ at which 
time 3.0 ml of benzene were added. The contents were mixed immediate­
ly for 2 minutes by aeration with a rapid stream of air through a 
capillary pipette in each tube. The tubes were centrifuged at low 
speed to facilitate separation of the phases. The benzene phase was 
transferred to another set of tubes. Six ml of 10# NaCOg solution 
were added and mixed as above, and, if necessary, centrifuged. Five 
ml of the lower carbonate layer were transferred to a colorimeter 
tube held in the water bath at 25 C. At definite intervals (30")
5 ml of 1,5 N NaOH solution were added in turn to each tube. At 
the end of 5 minutes the densities were read (having first set the 
blanks to 100# T) at a wavelength of 435 nip.
A standard curve of pyruvic acid, with a range from 0.1 pmole 
to 1.0 pmole of pyruvic acid, was established by this same method, 
Friedmann’s method is based upon the separate determination 
of keto acids due to differences in the rates of reaction with 
2,4-dinitrophenylhydrazine and the distribution of the hydrazones 
in the aqueous phase and various solvents. At 25 C the monocarboxylic 
acids (such as pyruvic acid) react completely with the hydrazine in 
about 4 minutes; the dicarboxylic acids react within about 20
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minutes (Friedmann, 1957)*
(11) Enolase and mutases
Mutase catalyzes the conversion of 3-PGA into 2-PGA and 
enolase converts this latter substance into phosphoenolpyruvic 
acid. The activity of these two enzymes was demonstrated by the 
formation of pyruvic acid from 3-PGA by cell-free extracts of B * 
pertussis.
The incubation method was almost the same as that for pyruvic 
kinase, but 40 |imoles of 3-PGA were substituted for the PEPA and 0.4 
ml of Tris buffer, pH 7.4 was substituted for the 10 jxmoles KCl.
The test for pyruvic acid was the Friedmann method for the 
determination of -keto acids.(See above for details),
(12) TPN-linked malic dehydrogenase;
A "malic" enzyme exists, which, in the presence of TPN, converts 
malic acid to pyruvic acid. A spectrophotometric method (Ochoa, 1955) 
is used to demonstrate the activity of this enzyme.
The reaction mixture contained 100 |amoles barbital buffer, pH 
8.0, 0.5 ml cell-free extract and 20 r̂nioles dl-malic acid. The reaction 
proper was started with the addition of 0.5 jmnole TPN,
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RESULTS
In the experiments involving the use of the Beckman DH 
spectrophotometer, a unit of enzyme activity was defined as that 
amount which would cause an initial rate of change in absorbance 
0.01 per minute under the specified conditions of the 
experiment at room temperature (Wolff and Kaplan, 1955). The 
absorbancy change in the 15 to 30 second interval was taken as the 
initial change and multiplied by 4 to give the change per minute 
(DeMoss, 1955; Jyssum and Borchgrevlnk, I960). This appears to be 
the most widely used method of recording enzymatic activity. Since 
most enzyme reactions tend to slow down with time as a result of 
many factors, it is felt that only the first part of the reaction 
curve, which is usually a straight line, should be regarded as 
indicative of the reaction rate (Gray, I961). However, this method 
may also give rise to inaccurate representations in certain cases, 
notably those in which a reagent or endogenous blank shows a change 
in absorbancy during the 15-30 second interval and, although no 
further change may occur in the reaction, this ̂  is multiplied
by 4 to give an erroneously high blank.
For those experiments in which the formation of pyruvic acid 
from PGA or PEPA was taken as the endpoint, a unit of enzyme activity 
was defined as that amount which caused the formation of 0.10 pmoles
—29"
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of pyruvic acid in one hour of incubation at 37°C,
In all cases the specific activity is recorded as the number
of units per mg nitrogen (N),
(1) Glucose-é-ohosphate dehydrogenases
Extracts of E. coli showed high G-6-P dehydrogenase activity, 
but extracts of strains 1, 2 and 4 of B. pertussis were not active
(Fig. 1). No significant activity was demonstrable when DPN was used
as the GOenzyme instead of TPN*
All of the strains were tested in the presence of purified G—6—P 
dehydrogenase since it was felt that the added enzyme might be in­
hibitory toward this reaction in B, pertussis and toward those reactions 
which were coupled with it (hexokinase and phosphohexoisomerase). The 
reaction proceeded under these circumstances, but the activity demon­
strated was in no case significantly higher than the reagent blank 
(Fig. 1).
The nitrogen contents and absorbancy changes for all strains, 
under all conditions, are recorded in Table I.
(2) Hexokinase1
Since B. pertussis extracts exhibited no G-6—P dehydrogenase 
activity of their own, it was necessary to add 0.02 ml of purified 
Zwischenferment in order to demonstrate hexokinase by a spectrophoto— 
metric method. Even in the presence of added enzyme, the B. pertussis
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Figure 1. Glueose-6-phosphate dehydrogenase activity in Bordetella pertussis 
(strains 1,2 and 4) and E, coli extracts with TPN or DPN as coenzyme*
#1 with Zwischenf erment (Z) Reag* with Z ^ ^  #2 & reag without 2
o- - -o #2 '* " •— » E. coli without Z ^ ^  #1 & 4 with DPN
#4 SCI Ml Endog.
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Table I. Glucose-6-phosphate dehydrogenase activities of Bordetella 
pertussis (strains 1,2 and 4) and Escherichia coli extracts.
Strain mg N/ml 
extract 15-30"
/min Units/ml Spec.Act 
U/me N
E* coli 0.75 0.035 0.14 25 373
E. coli 0.69 0.05 0.20 40 58
E# coli 0.26 0.035 0.14 28 104
#1 1.09 0.005 0.02 0* —
#2 0.80 0.003 0.012 0* —
#4 1.05 0.005 0.02 0*
Reagent-5^ 0.085 0.34 0* —
#1«* 0.75 0.09 0.36 0* -
#2** 1.01 0.075 0.30 0* —
# 4 ^ 0.73 0.065 0.26 0* —
2.50 0.01 0.04 0* **
1.35 0,01 0.04 0* —
* not significantly higher than endogenous or reagent blanks
** plus added glucose—6—phosphate dehydrogenase 
with DPN as coenzyme instead of TPN
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extracts exhibited no activity that was significantly higher than 
the blanks.
In Figure 2 it can be seen that E, coli extracts, with or 
without added enzyme possess hexokinase activity, with the G-6-P 
dehydrogenase apparently the rate limiting factor in the over-all 
reaction.
The nitrogen content and absorbance changes of all strains, 
and the specific activities of the E. coli extracts are shown in 
Table II.
(3) Phosphohexoisomerase:
Due to the contamination of the added G-6-P dehydrogenase with 
phosphoglucoisomerase, the reagent blanks in this reaction were very 
high. The relative phosphohexoisomerase activities of the extracts,
E, coli and _B, pertussis, and the reagent blanks are shown in Figure 3»
It was noted (Table III) that in all cases where the B, pertussis 
extract was suspended in phosphate buffer the reaction was consistently 
lower than that of the blank. However, when these extracts were 
suspended in barbital buffer, the change in absorbance equalled that 
of the blank.
The results from method (b) for phosohohexoisomerase showed 
high enzyme activity in the E, coli extracts, while the B. pertussis 
extracts never exceeded the blanks \Fig. 4) although the nitrogen con­
tents were similarly high in all extracts (Table IV).
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Figure 2. Hexokinase activity of Bordetella pertussis (strains 1,2 and 
4) and Escherichia coli extracts*
X— X E« coli with Zwi sc hen ferment 
* * E# coli without Zwischenf erment
^ ̂ 1 with Zwischenferment 
O o §Zf #4, reagent and endogenous with Zwischenf erment
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ïable II* Hexokinase activities of extracts of Bordetella pertussis
(strains 1, 2 and 4) and Escherichia coli.
Strain mg N/ml 
extract
A A 31̂0 
15-30"
Units/ml Spec. Act. 
U/mg N
E. coli 0.75 0.02 0.08 16 21.3
E. coli 0.69 0.015 0.06 12 17.3
E. coli-*̂ 0.41 0,04 0.16 32 7Ô
#1* 0.01 0.008 0.032 0** —
0.17 0,005 0.02 0** -
#4* 0.87 0.005 0.02 0** —
* plus added glucose-6-phosphate dehydrogenase 
** not significantly higher than reagent or endogenous blanks
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Figure 3« Phosphohexoisomerase activity of Bordetella pertussis (strains 
1, 2 and 4) and Escherichia coli extracts in the presence of added 
Zwischenferment.
X— ^  E. coli
Reagent average and #1, #2 and #4 in barbital buffer
#1 and #4 in phosphate buffer #2
Endogenous
I
I
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Table III* Phosphohexoisomerase activities of extracts of Bordetella 
pertussis (strains 1,2 and 4) and Escherichia coli in the presence of
added glucose-6-phosphate dehydrogenase*
Strain mg N/ml 
extract
A
15-30"
/min Units/ml*^** Spec* Act.*** 
U/mg N
E* coli 0.42 0.05 0*20 20 47*6
Reagent* — 0.025 0*10 — -
il 0*75 0.02 0.08 — —
#2 1.01 0,015 0.06 - -
#4 0.75 0*02 0,08 — —
#1 0.01 0.02 0*08 - —
#2 0.26 0.017 0.068 — —
#4 0.11 0.018 0*072 — -
#2 0.17 0*01 0.04 - -
#2 0.10 0*013 0*052 - —
#4 0.87 0*02 0.08 — —
#1** 0*61 0.025 0.10 — —
#2** 0.35 0*025 0.10 — —
0.02 0.025 0.10 — —
* average of 7 runs
** cells washed and extracted with barbital buffer, pH 7*0, instead 
of the customary phosphate buffer 
*** corrected for reagent blank*
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Figure 4. Phosphohexoisomerase activity of extracts of Bordetella pertussis 
(strains 1, 2 and 4) and Escherichia coli. Coupled with the aldolase- 
^ —glycerophosphate dehydrogenase system,
^ ^  i6̂1* #2, #4> reagent and endogenous 
X— X £• coli
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Table ZW* Phosphohexoisomerase activities of Bordetella pertussis 
(strains 1, 2 and 4) and Escherichia coli extracts*
Strain mg N/ml 
extract 15-30»
Units/ml Spec. Act* 
U/mg N
E* coli 0.80* 0.03 0.12 60 750
#1 1.01 0 0 — —
#1 1.35 + 0.005 + 0.02 - —
#2 1.00 + 0.005 + 0.02 — -
#4 1.26 + 0.005 + 0.02 — —
#4 0.65 0 0 —
* 0*2 ml of a 1:10 dilution of E. coli extract was used in the experiment
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(4) Aldolase;
Strains 1, 2 and 4 of B. pertussis all demonstrated aldolase 
activity (Fig. 5)* The specific activities for these strains are 
recorded in Table V*
(5) Phosphofructokinase;
The relative phosphofructokinase activities of the three strains 
of B. pertussis enployed are shown in Figure 6. All strains exhibited 
a very high PFK activity (Table VI)*
(6) Triose phosphate isomerase;
No evidence was presented to indicate that _B. pertussis possessed 
this enzyme. This was a case where the method for recording enzymatic 
activity presented a fallacious picture. In Figure 7 it appears that 
strain #4 of B. pertussis shows some slight isomerase activity, whereas 
in fact, the final change in absorbance, after six 15—second readings, 
was less than half that of the reagent blank.
From the high reagent blanks it would appear that the added 
di-glycerophosphate dehydrogenase was contaminated with triose phosphate 
isomerase. Experiments were run using both 0.001 ml and 0,0001 ml of 
the added enzyme.(Table VII)•
(7) <3 -̂glycerophosphate dehydrogenases
Figure 8 and Table VIII show that no -glycerophosphate
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Figure 5# Aldolase activity of extracts of Bordetella pertussis, 
strains 1, 2 and 4«
•— • Reagent and endogenous 
X— X #1 #2 
A A
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Table V. Aldolase activity of Bordetella pertussis extracts.
Strain mg N/ml 
extract
A
15-30'"
/min Units/ml Spec. Act. 
U/mg N
#1 0.74 0.015 0.06 60 81
#2 0.75 0.02 0,08 80 106.6
#4 0.77 0.025 0.10 100 129.8
#4 0.44 0.015 0,06 60 136.3
#2* 0.63 0.02 0,08 40 63.5
#1* 0.72 0.02 0,08 40 55.5
* 0.2 ml extract used instead of 0.1 ml.
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Pigtire 6. Phosphofructokinase activity of extracts of Bordetella pertussis. 
strains 1, 2 and 4*
•— • Endogenous and reagent 
o— o #2 
/— / £L 
^— A #4
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Table VI* Phosphofructok±nase activity of Bordetella pertussis extracts^
Strain mg N/ml 
extract
A
15-30*
/min Units/ml Spec. Act. 
U/mg N
m. 1.01 0.025 0.10 50 49.5
#4 0*65 0.03 0.12 60 92.3
#2 0.86 0.015 0.06 30 34.8
#2 0*84 0.02 0.08 40 47.6
#2 1.00 0.055 0.22 no no.o
#1 2.50* 0.03 0.12 60 240.0
#4 1.35* 0.03 0.12 60 444.0
* 0*2 ml of a It10 dilution of extract used.»
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Figure 7* Triose phosphate isomerase activity in extracts of Bordetella 
pertussis (strains 1,2 and 4) and Escherichia coli*
X— Y Reagent 
E* coli
Endogenous
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Table VII. Triose phosphate isomerase activities of extracts of 
Bordetella pertussis (strains 1, 2 and 4) and E. coli.
Strain mg N/ml 
extract
A A 3*0
15-30'»'
/&Ag^o/min Units/ml Spec. Act.
U/mg N
plus 0.001 ml 0{-glycerophosphate dehydrogenase
Reagent 0.12 0.4® — —
#1 1.75 0.13 0.52* — —
#2 1.53 0.10 0.40^ — —
#2: 1.53 0.12 0 a 4S^ — —
#4 1.35 0.10 0.40^ — —
#4-Endog 1.35 0.01 0.04 — “
plus 0.0001 ml o( -glycerophosphate dehydrogenase
Reagent 0.015 0.06 — —
#4 0.61 0.02 0.08^ — —
E. coli 0.87 0.03 0.12 12** 13.7
* not significantly higher than blank 
** corrected for reagent
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Figure 8, Ol-glycerophosphate dehydrogenase activity of extracts of B, pertussis (strains 1,2 and 4) 
and Escherichia coli.
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Table Vlil« Ct-gly-cerophosphate dehydrogenase activities of extracts of 
Bordetella pertussis (strains 1, 2 and 4) and Escherichia coli.
Strain mg N/ml 
extract
A A 3*̂0 
15-30"
x̂ Agya /min Units/ml Spec. Act, 
U/me N
without added enzyme
Reagent 0 0
E. coli 0.87 0.005 0.02 4 4.5*
a 1.75 0 0 -
#2 1.53 0 0 —
#4 1.31 0 0 - -
#4 0.61 -rO.Ol + 0.04 — -
E.coli-End 0.87 0 0 - -
#L-Endog 1.75 + 0.02 + 0.08 —
plus 0.01 ml triose phosphate isomerase
Reagent 0.015 0.06
#4 0.61 0.015 0.06 —
E. coli 0.87 0.045 0.18 24** 27.5
E.coli-End 0.87 0 0 —
* coupled system requires both triose phosphate isomerase and 
-glycerophosphate dehydrogenase 
** corrected for reagent
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dehydrogenase activity was demonstrable in B. pertussis either with 
or without the addition of purified triose phosphate isomerase. The 
high reagent blanks obtained in the presence of added enzyme would 
seem to indicate that the triose phosphate isomerase was contaminated 
with Ci -glycerophosphate dehydrogenase.
The extracts of E. coli exhibited enzyme activity in both systen^.
(8) Phosphoglycerokinase;
Either 0.2 or 0.02 ml aliquots of purified GA-3-P dehydrogenase 
were added to the reaction mixtures « The differences in activity 
caused by these amounts were very slight (Fig. 9). In both cases, 
strain #2 exhibited the greatest enzyme activity; however, when §2 
was corrected for its unusually high endogenous reaction, the resulting 
specific activity was more nearly equal that of the other 2 strains 
(Table IX).
(9) Glyceraldehyde-3—phosphate dehydrogenase*
Because of the slow rate at which this reaction proceeds, a 
slight variation was employed in the method of representation. The^ 
for the 13-60 second interval was taken as the initial rate of change, 
and multiplied by 5 to give a 3-minute span to the graph (Fig. 10). As 
in the above case, strain #2 exhibited the highest GA-3-P dehydrogenase 
activity (Table X).
In spite of the different method of representation, a unit of
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Figure 9* Phosphoglycerokinase activity of extracts of Bordetella pertussis.
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T a b l e  I X ,  P h o s p h o g l y c e r o k i n a s e  a c t i v i t y  o f  B o r d e t e l l a  p e r t u s s i s  extracts<
Strain mg N/ml & Ag^^/min Units/ml Spec, Act,
___________extract 15-30"  U/mg H
plus 0,2 ml glvceraldehyde-3-phosphate dehydrogenase_____
#1 0,67 0.035 0.14 28 41.7
#2 1.34 0.10 0.40 48* 35,8
#4 1.03 0.04 0.16 32 31.1
plus 0,02 ml glyce:raldehyd e—3-pho sphate dehydro genase
#1 0.84 0.063 0.26 52 61,9
#2 0,77 0.07 0.28 36* 46,7
#4 0.80 0.055 0.22 44 55.0
corrected for endogenous
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Figure 10. Glyceraldehyde-3-phosphate dehydrogenase activity in extracts 
of Bordetella pertussis, strains 1,2 and 4»
^— X Reagent and endogenous
A— A  #4 O— O #2 
# '#1
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T a b l e  X »  G l y c e r a i d e h y d e - 3 - p h o s p h a t e d e h y d r o g e n a s e  a c t i v i t y  o f
B o r d e t e l l a  p e r t u s s i s  e x t r a c t s *
Strain mg N/ml 
extract
^ 3  HO
15-60»
A min Units/ml Spec. Act. 
U/mK N
#1 0.82 0.015 0.075 3 3.7
#1 0.84 0.02 0.10 4 4.8
#2 1.34 0.09 0.45 18 13.4
#2 0.77 0.10 0.50 20 25.2
1.03 0.01 0.05 2 1.9
#4 0.80 0.015 0.075 3 3.7
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enzyme activity was still defined as previously.
(10) Pyruvate kinase:
For this and the following ennzyme determinations (enolase and 
mutase), the pnoles of pyruvic acid formed from the substrate by the 
enzyme during incubation were determined from a standard curve pictured 
in Figure 11.
Figure 12 and Table XI show the relative pyruvic kinase activities 
of strains #1, 2 and 4 of B. pertussis.
(11) Enolase and mutase:
The extracts of all three strains of B. pertussis catalyzed the 
formation of pyruvic acid from 3-phosphoglyceric acid, thereby indicating 
the presence of the enzymes enolase and mutase in these extracts. The 
results of these experiments are given in Figure 13 and Table XII.
(12) TPN-linked malic dehydrogenase:
Evidence was also presented for the existence of a TPN—linked 
malic dehydrogenase in cell—free extracts of B, pertussis (Fig* 14 
and Table XIII)*
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Figure 12, Pyruvic kinase activity of extracts of Bordetella pertussis.strains,
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T a b l e  X I ,  P y r u v i c  k i n a s e  a c t i v i t y  i n  e x t r a c t s  o f  B o r d e t e l l a  p e r t u s s i s .
Strain mg N/ml* 
extract
pnol pyruvic** 
per 20 min
pnol pyruvic 
per hour
Units/ml Spec,Act. 
U/mg N
#1 0,79 1.125 3.375 33.8 41*9
#1 0.17 0,023 0.069 0.7 4.1
#1 0.31 0.79 0.237 2.4 7.7
#1 0,64 0,078 0.234 2,3 3.6
#2 0,22 0,023 0.069 0,7 3.2
#2 0.40 0,003 0.009 0,1 0.25
#4 0,66 0,37 1.11 11,1 16,0
#4 0,26 0,076 0.228 2,3 8,8
#4 0,56 0,488 1.464 14.6 26,1
** corrected for endogenous and reagent blanks
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Figure 13. Enolase and mutase activities of extracts of Bordetella 
pertussiSj strains 1, 2 and 4.
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T & b l e  X I I ,  E n o l a s e  a n d  m u t a s e  a c t i v i t i e s  o f  B o r d e t e l l a  p e r t u s s i s  e x t r a c t s .
Strain mg N/ml* 
extract
|umol pyruvic** 
per 20 min
pmol pyruvic 
per hour
Units/ml Spec, Act, 
U/mg N
#1 0,28 0,31 0,93 9.3 33.2
#1 0,46 0.16 0,48 4.8 10.4
#1 1.17 0,21 0,63 6,3 5.4
#1 0,31 0,21 0,63 6.3 20.3
#2 1.23 0.42 1.27 12,7 10.3
#2 0,77 0,24 0.74 7.4 9.6
n 0,21 0.17 0,51 5.1 24.3
#4 1.35 0,39 1.16 11.6 8,6
#4 0.82 0,07 0.23 2,3 2,8
** corrected for endogenous and reagent blanks
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Figure 14. TPN-linked malic dehydrogenase activity in extracts of 
Bordetella pertussis, strains 1, 2 and 4.
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Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
-61-
Table XllX. TPN-linked malic dehydrogenase activity of Bordetella pertussis
extracts
Strain mg N/ml 
extract
A A
15-30"
/min Units/ml Spec, Act, 
U/mg N
#1 1.75 0,017 0.068 13.6 7.7
#2 1.53 0.02 0.08 16,0 10.5
#4 1.35 0.015 0.06 12.0 8.8
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CHAPTER V
DISCUSSION
Enzyme activity is influenced by many factors, such as pH, 
temperature, concentration of the reaction products, concentration of 
the substrate, activators and inhibitors. Slight variations in any of 
these factors can affect the exact duplication of results (Harrow et 
al,, i960). This could account for the occasionally large discrepancies 
in the specific activities of an extract for any given enzyme. However, 
the main purpose of this work was not to characterize a particular 
enzyme, but rather, to demonstrate which, if any, of the glycolytic
enzymes are present in extracts of Bordetella pertussis.
Glycolysis can be defined as the sequence of reactions which 
results in the conversion of free monosaccharides to lactic acid or
pyruvic acid, (Bueding and Farber, I96O), and, as such, Abe (1953)
felt that this pathway could not exist in B, pertussis because of the 
inability of this organism to oxidize sugars. On the other hand, a 
reversion of glycolysis is considered to be one of the mechanisms for 
the synthesis of monosaccharides within the cell (Leloir, Cardini and 
Cabib, i960) and it has been postulated that the glycolytic pathway is 
at least partially operative in B. pertussis for the production of 
polysaccharides (Kobayashi and Fukimi, 1954)* In this "inverted" 
glycolytic pathway, pyruvate may be considered as a key metabolite 
since the conversion of fats and amino acids to carbohydrates takes
-62-
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place through the intermediary formation of pyruvic acid (Leloir, 
Cardini and Cabib, I960)*
It seems to be a fairly well established fact that glutamic acid 
oxidation is the primary energy source for B. pertussis and that new 
substances are introduced into the TCA cycle via ^ -ketoglutaric acid 
(Jebb and Tomlinson, 1951; Rowatt, 1955)*
Within the TCA cycle there is a DPN-linked malic dehydrogenase 
which converts mala te to oxaloacetate* There siso exists a TPN—linked 
malic dehydrogenase which converts malate to pyruvate* In pigeon liver 
and wheat germ extracts this latter "malic" enzyme requires manganese 
ions for activation (Ochoa, 1955). This activator is apparently not 
necessary in extracts of B. pertussis since they reduced TPN in the 
presence of malic acid and buffer without the addition of Mn% TPN— 
malic dehydrogenase is probably not the only enzyme capable of producing 
pyruvate from TCA intermediates, but it is still important as a source 
of the starting material for reverse glycolysis.
Pyruvic acid formation by B* pertussis extracts from 3—PGA and 
PEPA demonstrated the presence of pyruvic kinase, enolase and mutase 
in these extracts. The specific activities for enolase and mutase 
were higher than those for the kinase, however, 4 times the amount of 
substrate was used in the demonstrations of the first 2 enzymes than 
in the third. Enolase is specific for 2-PGA and PEPA (Axelrod, 1960(a)); 
therefore, the production of pyruvate from 3-PGA would necessarily 
imply the presence of the mutase which converts 3-PGA to 2-PGA*
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Pyruvic kinase catalyzes a transfer of phosphate from PEPA to 
ADP • This reaction has been shown to be completely reversible in the 
presence of Mg, ATP and K or ions, (Axelrod, 1960(a)), and is the 
first step in the synthesis of sugars from pyruvate.
Both phosphoglycerokinase and GA-3-P dehydrogenase activities 
were demonstrated in extracts of B. pertussis. Apparently the dehydro­
genase is the limiting factor in this system in B. pertussis as it is 
in Neisseria meningitidis (Jyssum, Borchgrevink and Jyssum, I96I). An 
unusually high endogenous blank was consistently noted in the p ho spho— 
glycerokinase activity of strain #2. The cells of this strain showed 
a far greater tendency toward clumping during the washing procedure 
than did the other strains used, perhaps resulting in an ihconplete 
removal of substrate which might account for the high endogenous 
activity.
Contrary to what might be expected, neither triose phosphate 
isomerase nor d-glycerophosphate dehydrogenase activity was demonstrated 
in B, pertussis extracts. E. coli. however, showed a low but definite 
activity for both of these enzymes. In the other experiments which 
utilized this particular dehydrogenation system purified triose phosphate 
isomerase/ol —glycerophosphate dehydrogenase was always added.
The lack of isomerase activity in B. pertussis extracts may be 
due to the absence of the enzyme in B. pertussis or to the inability 
of the method used to detect small amounts of the enzyme. However, in 
regard to the latter postulate, the spectrophotometric method is felt
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to be one of the most sensitive for the determination of enzyme activity, 
and this enzyme was detectable in extracts of E, coli. Nutrient 
utilization of the glycerol in B-G medium (Dawson et al., I95I;
Magasanik, Brooke and Karabian, 1953) would seem to be ruled out by 
the lack of C^-glycerophosphate dehydrogenase activity in B. pertussis 
extracts.
High activities for both aldolase and phosphofructokinase were 
demonstrated in extracts of B, pertussis. The specific activity for 
the kinase appeared to be somewhat higher than that for aldolase, but 
the strain variation remained about the same for both enzymes with 
strain #4 exhibiting the highest amount of activity and strain #2 the 
lowest amount. The presence of aldolase in B, pertussis extracts 
agrees with the findings of Kobayashi and Fukimi (1954)#
Also in agreement with these workers was an inability to demon­
strate the presence of hexokinase activity in this organism. The method 
they used was based upon the formation of acid-labile phosphate and 
inorganic phosphate, and the slight activity which occurred they 
attributed to an ATPase present in the extracts, Hexokinase activity 
is present in all cells capable of utilizing free sugars (Axelrod, 
1960(a)), Some hexokinases, such as brain (Bueding and Farber, I96O) 
and yeast (Berger et al., 1946), exhibit broad substrate specificity, 
while others have a high specificity for a single substrate (Palleroni 
et al., 1956/ Doudoroff, Palleroni et al., 1956), In certain organisms, 
Clostridium botulinum (Simmons and Gostilow, 1962) and Pseudomonas
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saccharophila (Doudoroff, Palleroni et al,, 1956), hexokinase activity 
has been found to be inducible.
No work has yet been reported in which induction of hexokinase 
activity in B, pertussis has been attempted. From the evidence pre­
sented here it appears very probable that B, pertussis lacks a 
glucokinase, and from its inability to oxidize or ferment free sugars, 
it would appear equally probable that this organism lacks any kinase 
capable of phosphorylating unsubstituted monosaccharides.
By neither of the methods used was any hexosephosphate isomerase 
detected (i.e., specifically phosphoglucoisomerase; G-6-P^F—6-P). When 
F-6-P was used as the substrate, extracts suspended in phosphate buffer 
consistently showed lower activity than the reagent blank. However, 
when the extracts of these strains of B, pertussis were suspended in 
barbital buffer their activities equalled that of the reagent blank.
It was felt that this might be due to the utilization of the substrate 
by an enzyme in the extract which required only F—6-P and inorganic 
phosphate for activity, perhaps a fructose-6-phosphate phosphoketolase 
such as was found in Acetobacter xylinum by Racker (1962) which 
catalyzes the reaction:
F-6-P+Pi —> Erythrose-4-P-f-Acetyl-P+H^O 
No evidence was presented for either TPN- or DPN-linked G-6-P 
dehydrogenase activity in B. pertussis « This would seem to rule out 
the use of the hexosemonophosphate pathway for glucose catabolism in 
B. pertussis, but it would not necessarily invalidate the partial
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operation of this pathway for the synthesis of pentoses and other 
carbohydrates in this organism.
In certain species of Pseudomonas and Acetobacter another 
pathway for glucose catabolism, the Entner-Doudoroff pathway, has 
been described (Bueding and Farber, I96O). This pathway involves the 
formation of a phosphorylated intermediate, 2—keto-3—deoxy-6—phospho— 
gluconic acid and its subsequent cleavage to pyruvic acid and 
glyceraldehyde-3—phosphate. The first means by which this intermediate 
is formed requires the activity of G-6-P dehydrogenase, which is 
absent in B. pertussis extracts. The second involves the direct 
oxidation of glucose to gluconic acid followed by phosphorylation 
of the latter substance by a specific gluconokinase, Kobayashi and 
Fukimi (1954) were unable to demonstrate gluconokinase activity in 
B. pertussis, thereby apparently eliminating the Entner-Doudoroff path­
way as a possible means of glucose catabolism in this organism. It 
is conceivable, however, that the intermediates of this pathway could 
be formed, beginning with the aldolase-catalyzed condensation of 
pyruvic acid and glyceraldehyde-3-pb.o sphate to 2—keto-3-deoxy-6— 
phosphogluconolactone (Leloir, Cardini and Cabib, I96O),
Kobayashi and Fukimi (1954) hypothesized that the inability of 
B. pertussis to utilize free sugars was due to the lack of hexokinase 
rather than the lack of permeability, and that sugars could be and 
probably were synthesized and metabolized within the bacterial cell. 
Overend et al. (1951) found that DNA preparations of B. pertussis
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contained a polysaccharide component, probably in combination with 
the nucleic acid, and Akiya et al, (1951) found galactose, mannose 
and fructose to be present in B, pertussis cells, the galactose and 
mannose probably occurring as polysaccharide components.
The hexosemonophosphates formed from lower molecular weight 
compounds within the cell can be modified by a series of intercon­
version reactions, some of which lead to the formation of glycosyl 
derivatives which may then react with acceptors and lead to the 
synthesis of polysaccharides (Leloir, Cardini and Cabib, I960).
One of the mechanisms for the synthesis of complex polysaccharides, 
transglycosylation or transfructosylation, occurs according to the 
general reaction (Hassid, 1955):
R»OR« 4 R' "OH R»OR»» +  R"OH
Glycosyl donor Acceptor Product By-product
hexose-P; alcohols; hexose-P; mono- to poly-
sugar nucleotide; sugar-P; glycosides; saccharides;
di— to polysacchar— mono- to poly- di- to poly- Ĥ POy.;
ides. saccharides; saccharides. UDP.
H^PO^,
Since fructose-6-phosphate, fructose diphosphate, glyceraldehyde- 
3-phosphate and phosphoglyceric acid are all metabolized by B. pertussis, 
it can be assumed that they are also available for interconversion 
reactions. Mannose-6-phosphate could be fomed in the cell by the 
isomerization of fructose-6-phosphate, providing that B. pertussis 
contains one phosphohexoisomerase while lacking the other.
Galactose is not directly oxidized by extracts of B. pertussis
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(Abe, 1953; Jebb and Tomlinson, 1951). Doudoroff, DeLey et al. (1956) 
postulated a pathway in P. sac charophila for cell-free extracts of 
that organism grown on galactose, which involved the direct phos­
phorylation of 2“keto-3-deoxy-galactonic acid to 2-keto~3"deoxy‘-6— 
phosphogalactonic acid followed by cleavage to pyruvic acid and 
glyceraldehyde-3-phosphate. Kalckar (1957) found this mechanism to 
be apparently irreversible.
Since glucose-6-phosphate is not formed from fructose-6—phosphate 
and glucose is not directly phosphorylated it seems unlikely that 
galactose is formed in B. pertussis by the usual route involving 
uridine diphosphate (UDP).
Some glucose intermediate must be formed within B. pertussis 
since the conversion of other monosaccharides to galactose apparently 
requires the intermediary formation of glucose (Axelrod, 1960(b)j 
Leloir, Cardini and Cabib, I960), One means by which galactose may 
be synthesized in B. pertussis is through hexosamine metabolism. It 
has been shown that fructose-6-phosphate and glutamine (Axelrod, 
1960(b)) or ammonia (Leloir, Cardini and Cabib, I96O), in the presence 
of the necessary enzyme, will produce glucosamine-6-phosphate and 
glutamic acid or water, Glucosamine-6-phosphate can then react with 
acetyl coenzyme A to produce N-acetylglucosamine-6-phosphate and 
COenzyme A, The hexose sugar may be converted by a specific mutase 
to N-acetylglucosamine-l-phosphate, which, in turn, can react with 
UTP to form UDP-acetylglucosamine and inorganic pyrophosphate.
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Finally, an epimerization reaction may occur transforming UDP— 
acetylglucosamine into UDP-galactosamine which may serve as a sugar 
donor in the synthesis of polysaccharides (Axelrod, 1960(b)5 
Leloir, Cardini and Cabib, I960).
As yet, this pathway has not been studied in B. pertussis.
Some evidence exists, however, which might indicate that this mechanism 
is operative in B. pertussis. Of all the sugars tested as substrate 
for B. pertussis, a slight oxygen consumption was noticed only with 
glucosamine (Abe, 1953). The low 00^(26) which was observed could 
have been due to the fact that this substrate is not readily metabolized 
by B. pertussis, or to the fact that glucosamine-6-phosphate is being 
produced within the cell and competing for the available enzyme.
Gerhardt et al, (1950), studying the utilization of single amino 
acids for growth by Brucellae, hypothesized that amino acids may 
serve as organic sources of ammonia, which in turn serves as the 
primary nitrogen source for synthetic reactions. During the oxidation 
of glutamic acid by B. pertussis it was noted that the actual 
yield of ammonia was less than the expected theoretical yield, 
leaving some 20-30^ of the ammonia unaccounted for (Jebb and Tomlinson, 
I95I; Baddily, Rowatt and Standfast, 1952; Rowatt, 1955). Jebb and 
Tomlinson (1951) postulated that the missing nitrogen was incorporated 
into cell substance. It is very possible that this "cell substance" is 
glucosamine—6—phosphate.
From the data presented it seems probable that B, pertussis
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is incapable of catabolizing imsubstituted monosaccharides^ primarily 
because of the absence of hexokinase. The glycolytic enzymes which 
were demonstrated in extracts of this organism were those leading to 
the formation of substrates which could easily be converted into a 
variety of sugars within the cell. The glycolytic cycle is only 
partially operative in B. pertussis, and its principal function in 
this organism is probably the anabolism of carbohydrates rather 
than their catabolism.
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CHAPTER VI
SUMMARY
1* A survey was made to determine which glycolytic enzymes were 
present in extracts of strains 2927 (#!)• 53751*45 (#2) and 
5373L-2 (#4) of Bordetella pertussis.
2. Activities corresponding to phosphofmctokinase, aldolase, 
glyceraldehyde—3-phosphate dehydrogenase, phosphoglycerokinase, 
phosphoglyceromutase, enolase, pyruvic kinase and TPN-linked 
malic dehydrogenase were demonstrated in these extracts.
3. No activities were demonstrated corresponding to hexokinase, glucose— 
6—phosphate dehydrogenase, phosphoglucoisomerase, triose phosphate
isomerase and Ol-glycerophosphate dehydrogenase in these extracts.
4. The possibility of the presence of a fruetose-6-phosphate 
phosphoketolase was mentioned.
5. The inability of B. pertussis to catabolize sugars via the glycolytic, 
hexose monophosphate or Entner-Doudoroff pathways was discussed, 
together with the probability that those glycolytic enzymes which
are present in B, pertussis are primarily involved in the synthesis 
of poly saccharides.
6. The possible formation of intracellular galactose in B, pertussis 
through a hexosamine metabolism was also discussed.
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